期刊文献+

IL-2单独或联合IL-12活化骨髓抗肿瘤效应研究

Study on Anti-tumor Effect of Activated Bone Marrow by IL-2 Alone or Combine IL-12
下载PDF
导出
摘要 目的 :研究白细胞介素 - 2 (IL - 2 )和白细胞介素 - 12 (IL - 12 )活化骨髓的抗肿瘤效应与重建造血功能 ;探讨活化骨髓的性质和杀伤肿瘤细胞的机制。方法 :测定活化骨髓杀伤肿瘤细胞的活性 ;检测活化骨髓的细胞表面分化抗原 ,特别是CD34+/CD38-细胞群的表达。结果 :活化骨髓与L12 10 细胞、新鲜白血病细胞共同培养后显示有杀伤肿瘤细胞作用 ,以培养 3~ 4天时最强 ;活化骨髓细胞的CD3、CD8、CD16、CD5 6分化抗原表达与新鲜骨髓相比升高 ,有显著性差异 (P <0 0 1)。L12 10 细胞、新鲜白血病细胞与活化骨髓共同培养后分化抗原CD71、CD95表达下降 ,超二倍体、亚二倍体等异倍体减少 ,与对照组相比有显著性差异 (P <0 0 5 ) ;活化骨髓中CD34+/CD38-细胞分化抗原表达与新鲜骨髓相比没有显著性差异 (P >0 0 5 )。IL - 12活化骨髓效靶比 (E∶T)稀释一倍后杀伤白血病细胞活性仍然比IL - 2活化骨髓明显 ;IL - 2联合IL - 12诱导后活化骨髓抗肿瘤活性进一步增强。结论 :活化骨髓具有抗肿瘤效应 ,其中有细胞毒T细胞、自然杀伤细胞的作用 ,也有凋亡机制参与 ;活化骨髓还保留有重建造血的功能 ;IL - 12活化骨髓比IL - 2活化骨髓的活性高 ;且IL - 2联合IL - Objective:To study Interlukin 2(IL 2)and IL 12 activated bone marrow anti tumor effect and the function of hempopoietic reconstruction; To study the nature of activated bone marrow and mechanisms of kill tumor cell.Methods:Assay the competence of activated bone marrow kill tumor cell; Detect cell surface differentiation antigen of activated bone marrow, particularly the expression of CD34+/CD38 cell group.Results:After activated bone marrow and L 1210 cell, fresh leukemia cell being cultured together, Action for kill tumor cell display, while 3 4 day the highest; Compared differentiation antigen expression of activated bone marrow CD3, CD8, CD16, CD56 with fresh bone marrow, difference is significant ( P <0 01). After L 1210 cell,fresh leukemia cell and activated bone marrow, being cultured together, differentiation antigen CD71, CD95 expression decreases, heteroploid (hyperdiploid,hypodiploid) reduces, there is significance in the difference compared with control group ( P< 0 05).Activated bone marrow CD34+/CD38 cell group differentiation antigen expression compares with fresh bone marrow, no significant difference ( P >0.05). After IL 12 activated bone marrow effect target ratio (E∶T)dilution 1 time, the action of kill leukemia cell still higher than IL 2 Activated bone marrow.Conclusion:There are anti tumor effects in the activated bone marrow, among cytotoxic T cell effect, nature killer cells action with the apoptosis mechanism together; Activated bone marrow retains the function of hemopoietic reconstruction. IL 12 activated bone marrow effects are higher than IL 2 activated bone marrow and was further increased when IL 2 in combination with IL 12.
出处 《临床肿瘤学杂志》 CAS 2002年第6期416-418,共3页 Chinese Clinical Oncology
基金 江苏省科委应用基础研究基金 (BJ - 96 0 11) 国际抗癌联盟 (UICC)ICRETT基金 ( 92 - 6 74 )资助
关键词 IL-2 IL-12 活化骨髓 抗肿瘤效应 研究 IL 2 IL 12 Activated bone marrow Anti tumor effect
  • 相关文献

参考文献9

  • 1Agah R, Malloy B, Kerner M, et al. Generation and characterization of IL-2 activated bone marrow cells as a potent graft vs[J]. Tumor effector in transplantation. J Immunol, 1989,143(9):3093-3099.
  • 2李成文,严文伟,郝玉书,韩明哲,邱录贵,刘汉芝,韩俊领,李新,冯四洲.IFN-α联合IL-2激活的骨髓对白血病细胞的细胞毒作用[J].中国实验血液学杂志,1996,4(4):403-404. 被引量:2
  • 3Lehmann C, Zeis M and Uharek. Activation of natural killer cells with interleukin-2(IL-2) and IL-12 increases perforin binding and subsequent lysis of tumor cells[J]. Br J Haematol, 2001, 114(3):660-669.
  • 4Lehmann C, Zeis M, Schmitz N, et al. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells[J]. Blood, 2000, 96(2):594-600.
  • 5Uharek L, Zeis M, Glass B, et al. High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2[J]. Leukemia,1996,10, 1758-1764.
  • 6Wang K S, Frank D A and Ritz J. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4[J]. Blood, 2000, 95(10):3860-3866.
  • 7孙万军,郭子宽,艾辉胜.IL-2单独或联合IL-12增强G-CSF动员的人外周血单个核细胞抗肿瘤活性的研究[J].中国实验血液学杂志,2001,9(4):333-337. 被引量:7
  • 8S-L Lin, L-Y Wang, Y-J Huang, et al. Effect of interleukin (IL)-12 and IL-15 on apoptosis and proliferation of umbilical cord blood mononuclear cells[J]. Bone Marrow Transplantation, 2001, 28(5):439~445.
  • 9D Valteau-Counanet, E Angevin, C Leboulaire, et al. In vitro generation of cytotoxic effectors activated by interleukin2 (IL-2): comparison of autologous peripheral blood stem cells (PBSC) from adults and children[J]. bone Marrow Transplantation, 2001, 27(8):869-8756.

二级参考文献10

  • 1何金生,宗庭益.LDH释放法检测NK细胞活性的方法学研究[J].中国实验临床免疫学杂志,1996,8(2):10-13. 被引量:24
  • 2Korbling M, Mirza N, Thall P, et al. 100 HLA-identical allogeneic blood stem cell transpalntation: the M.D. Anderson Cancer Center experience. Bone Marrow Transplant,1997; 19(Suppl 1):s72
  • 3Dreger P, Haferlach T, Eckstein V, et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol, 1994; 87:609 -613
  • 4Verma UN, Areman E, Dickerson SA, et al. Interleukin-2activation of chemotherapy and growth fcator-mobilized peripheral blood stem cells for generation of cytotoxic effectors. Bone Marrow Transplant, 1995, 15:199 - 206
  • 5Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor(NKSF),a cytokine with multiple biologic effects on human lymphocytes. J Exp Med, 1989; 170:827 - 845
  • 6Chehimi J, Valiante NM, D'Andrea A, et al. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumorderived and virus-infected cells. Eur J Immunol, 1993; 23:1826 - 1830
  • 7Uharek L, Zeis M, Glass B, et al. High lyric activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2. Leukemia, 1996; 10:1758-1764
  • 8Rossi AR, Pericle F, Rashleigh S, et al. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. Blood, 1994; 83: 1323 -1328
  • 9Cesano A, Visonneau S, Clark SC, et al. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J Immunol, 1993; 151:2943- 2957
  • 10Chan SH, Perussia B, Gupta JW, et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responders cells and synergy with other inducers. J Exp Med, 1991; 173:869 - 879

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部